Oct 30, 2024 / 01:00PM GMT
Saurabh Paliwal - Biocon Ltd - Investor Relations
Good evening, everyone. I am Saurabh Paliwal from Biocon's Investor Relations team, and I welcome you to the Biocon's earnings call for the second quarter of fiscal year '25. (Event Instructions) Please note that the chat box is disabled, but you can raise any technical concerns by sending us an e-mail to [email protected].
I would like to bring your attention that this conference call is being recorded. The recording will be available on our website within a day. And the transcript will be made available subsequently. To discuss this quarter's business performance and future outlook for the company, we have with us on the call, Group CEO, Mr. Peter Bains, Mr. Siddharth Mittal, CEO and MD of Biocon Limited; Mr. Shreehas Tambe, CEO and MD of Biocon Biologics Limited, along with other senior management colleagues across our business segments.
Before we begin, I would want to remind everyone about the safe harbor related to today's call. Comments made during the call may be forward-looking in nature, based on management's current
Half Year 2025 Biocon Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot